8.16-8.29 期间，医药生物板块涨幅为-6.59%，在所有板 块中位列第二十七位，跑输沪深300 指数4.72 个百分点；年 初至今，医药生物板块涨幅为-7.15%，跑输沪深300 指数7.96 个百分点。从子板块看，8.16-8.29 期间，医药商业、中药和 生物制品涨跌幅分别为-2.32%、-3.36%和-4.16%，跑赢整体板 块；化学制药、医疗器械和医疗服务涨跌幅分别为-7.24%、 -8.165%和-9.30%，跑输整体板块。从年初来看，中药、医疗 服务和生物制品涨跌幅分别为7.43%、3.06%和-5.40%，跑赢整 体板块；医疗器械、化学制药和医药商业涨跌幅分别为 -7.40%、-15.64%和-20.33%，跑输整体板块。

1．行情回顾 ........................................................................................................................................... 4

1.1 医药生物行情回顾 ····················································································································· 4

1.2 医药生物子板块行情回顾 ········································································································· 5

1.3 医药生物板块估值 ····················································································································· 6

1.4 医药生物板块个股表现 ············································································································· 7

2．行业要闻 ........................................................................................................................................... 7

3．投资建议 ........................................................................................................................................... 9

4．风险提示 ........................................................................................................................................... 9